Richmond, VANCT05720663Now EnrollingIRB Ready

Nonalcoholic Steatohepatitis Clinical Trial in Richmond, VA

Access cutting-edge nonalcoholic steatohepatitis treatment through this clinical trial at a research site in Richmond. Study-provided care at no cost to qualified participants.

Sponsored by Virginia Commonwealth University

Quick Self-Assessment

See if you qualify for this Richmond location

Preparing your pre-screening questions…

Expert Care in Richmond

Access nonalcoholic steatohepatitis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related nonalcoholic steatohepatitis treatment provided free

Apply for This Richmond Location

Check if you qualify for this nonalcoholic steatohepatitis clinical trial in Richmond, VA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Richmond

    Convenient for VA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Richmond site if eligible
  4. 4Begin participation

About This Nonalcoholic Steatohepatitis Study in Richmond

Nonalcoholic Steatohepatitis (NASH) is a condition with increased amount of fat, inflammation and scarring in the liver. In compensated cirrhosis, the liver is coping with this damage and maintaining its important functions. Decompensation occurs when the liver becomes unable to perform all of its functions adequately. Variceal hemorrhage (bleeding from abnormal vessels in the liver called varices), Ascites (abnormal build-up of fluid in the abdomen), and Encephalopathy (brain confusion as a result of the liver not being able to get rid of toxic substances) are three symptoms of liver decompensation. The purpose of this research study is to investigate better ways to routinely monitor the condition of patients with NASH with compensated cirrhosis and to better pinpoint the development of decompensation in the livers of these patients.

Sponsor: Virginia Commonwealth University

Who Can Participate

Inclusion Criteria

Adult patients with presence of NAFLD associated cirrhosis.
Cirrhosis: biopsy confirmed or Agile F (F4) score \> 0.45
NAFLD as an etiology of liver disease will be determined based on presence of any of the following:
Biopsy showing \>5% steatosis or
CAP \> 280 dB/m or MR-PDFF\>5%
If CAP \< 280 dB/m or MR-PDFF \<5%, then must have type 2 diabetes and or 2 or more features of metabolic syndrome for 5 years (cryptogenic cirrhosis)

Exclusion Criteria

Refusal to consent
Alcohol use \> 14/21 gm/week cutoff
Other causes of chronic liver disease
Hepatic and extrahepatic cancers expected to limit life expectancy \< 2 yrs
prior hepatic resections, TIPS, splenic embolization
prior decompensation events
inability to fit into MRI (failed hula-hoop test)
general contraindication for MRI contrast (GFR \< 30 ml/min)
contraindications for MRI
acute kidney injury
reduced kidney function (GFR \<30ml/min)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Richmond?

Yes, this clinical trial (NCT05720663) has an active research site in Richmond, VA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Nonalcoholic Steatohepatitis Treatment Options in Richmond, VA

If you're searching for nonalcoholic steatohepatitis treatment options in Richmond, VA, this clinical trial (NCT05720663) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Richmond research site is actively enrolling participants for this clinical trial. You'll receive care from experienced nonalcoholic steatohepatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all nonalcoholic steatohepatitis clinical trials near you to find additional studies recruiting in your area.

More NASH Trials in Richmond, VA

See all nash clinical trials recruiting in Richmond — not just this study.

Browse NASH Trials in Richmond

Ready to Join in Richmond?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Richmond, VA